GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Shiller PE Ratio

Carna Biosciences (TSE:4572) Shiller PE Ratio : (As of Jun. 20, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Carna Biosciences Shiller PE Ratio Historical Data

The historical data trend for Carna Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Shiller PE Ratio Chart

Carna Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Carna Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Carna Biosciences's Shiller PE Ratio

For the Biotechnology subindustry, Carna Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carna Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's Shiller PE Ratio falls into.



Carna Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Carna Biosciences's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Carna Biosciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-23.27/107.2000*107.2000
=-23.270

Current CPI (Mar. 2024) = 107.2000.

Carna Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -17.690 98.000 -19.351
201409 -15.960 98.500 -17.370
201412 -55.030 97.900 -60.258
201503 11.300 97.900 12.373
201506 64.680 98.400 70.464
201509 -13.290 98.500 -14.464
201512 -13.920 98.100 -15.211
201603 -1.280 97.900 -1.402
201606 -2.430 98.100 -2.655
201609 -15.810 98.000 -17.294
201612 -12.120 98.400 -13.204
201703 -12.800 98.100 -13.987
201706 -21.230 98.500 -23.105
201709 -20.430 98.800 -22.167
201712 -24.070 99.400 -25.959
201803 -20.360 99.200 -22.002
201806 -30.810 99.200 -33.295
201809 -34.650 99.900 -37.182
201812 -39.200 99.700 -42.149
201903 -23.160 99.700 -24.902
201906 132.194 99.800 141.996
201909 -10.470 100.100 -11.213
201912 -28.110 100.500 -29.984
202003 -15.250 100.300 -16.299
202006 -17.350 99.900 -18.618
202009 -20.330 99.900 -21.816
202012 -37.400 99.300 -40.375
202103 -23.090 99.900 -24.777
202106 -39.470 99.500 -42.524
202109 -31.680 100.100 -33.927
202112 48.361 100.100 51.791
202203 -1.120 101.100 -1.188
202206 -25.410 101.800 -26.758
202209 -32.030 103.100 -33.304
202212 -40.540 104.100 -41.747
202303 -32.780 104.400 -33.659
202306 -21.433 105.200 -21.840
202309 -20.107 106.200 -20.296
202312 4.517 106.800 4.534
202403 -23.270 107.200 -23.270

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Carna Biosciences  (TSE:4572) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Carna Biosciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Carna Biosciences (TSE:4572) Business Description

Traded in Other Exchanges
N/A
Address
BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines